Log In
Print
BCIQ
Print
Print this Print this
 

SelG1

  Manage Alerts
Collapse Summary General Information
Company Selexys Pharmaceuticals Corp.
DescriptionHumanized mAb against P selectin (SELP)
Molecular Target P selectin (SELP) (CD62P)
Mechanism of ActionAntibody
Latest Stage of DevelopmentPhase I
IndicationSickle cell disease
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today